Polycystic ovary syndrome (PCOS) affects 8–13% of women. The Rotterdam diagnostic
criteria include polycystic ovarian morphology (PCOM) on ultrasound, but given recognized …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting young
women. Even though the definition of PCOS has changed over the years, all diagnostic …

Importance As part of the 2023 International Evidence-based PCOS Guideline, this meta-
analysis investigated the inclusion of Anti-Müllerian Hormone (AMH) in the diagnostic …

Background To evaluate role of AMH as a diagnostic tool for PCOS. Methods This was a
prospective case–control study on women attending Gynae OPD of Dr RML Hospital, New …

Aim To determine the diagnostic accuracy of anti‐Mullerian hormone (AMH) in the diagnosis
of polycystic ovary syndrome (PCOS). Methods Two independent reviewers searched the …

Androgens can have variable effects on men and women. Women may be evaluated for
androgen excess for several reasons. Typically, young premenopausal women present with …

Background One of the most challenging aspects of treating patients facing primary ovarian
insufficiency, especially those eligible for controlled ovarian hyperstimulation (COH), is the …

Aim The present study was conducted to correlate serum AMH levels with Polycystic Ovarian
Syndrome (PCOS) and type of treatment protocol. Materials and Methods Serum AMH levels …

Polycystic ovarian syndrome (PCOS) is an endocrinal disorder characterized by multiple tiny
cysts, amenorrhea, dysmenorrhea, hirsutism, and infertility. The current diagnostic tools …

Background and objective Polycystic ovary syndrome (PCOS), as a major hormonal issue
among reproductive age women, is categorized into four phenotypes regarding …